S100A16 and familial pancreatic carcinoma: Multiple groups have elucidated the role of S100A16 in promoting pancreatic cancer metastasis, which in part was shown to be driven via AKT and ERK pathways and impinging upon EMT to drive invasion and migration [15, 37].